Poseida Therapeutics

About:

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Website: http://poseida.com

Twitter/X: PoseidaThera

Top Investors: Novartis, Fidelity, Perceptive Advisors, Schonfeld Strategic Advisors, Longitude Capital

Description:

Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors.

Total Funding Amount:

$460M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)poseida.com

Founders:

Eric Ostertag

Number of Employees:

251-500

Last Funding Date:

2023-08-07

IPO Status:

Public

© 2025 bioDAO.ai